New Jersey-based pharmaceutical manufacturer agrees to pay over $2 million to settle allegations
U.S. Attorney Philip Sellinger announced the deal settles allegations Novel Laboratories violated the Controlled Substances Act.
News 12 Staff
•
Apr 11, 2024, 11:28 AM
•
Updated 25 days ago
Share:
More Stories
2:54
Fitness in Four: Improve your posture
15h ago2:06
New guidance says women need to be screened for breast cancer at 40 or younger
yesterday1:32
Knowing the early warning signs during Stroke Awareness Month
2ds ago2:47
Fitness in Four: Build strength for the summer
5ds ago3:17
be Well: Myths about seasonal allergies
5ds ago0:33
What marijuana reclassification means for the United States
5ds ago2:54
Fitness in Four: Improve your posture
15h ago2:06
New guidance says women need to be screened for breast cancer at 40 or younger
yesterday1:32
Knowing the early warning signs during Stroke Awareness Month
2ds ago2:47
Fitness in Four: Build strength for the summer
5ds ago3:17
be Well: Myths about seasonal allergies
5ds ago0:33
What marijuana reclassification means for the United States
5ds agoA drug manufacturer based in Somerset has agreed to pay $2.25 million to the federal government.
U.S. Attorney Philip Sellinger announced Wednesday that the deal settles allegations Novel Laboratories violated the Controlled Substances Act.
Officials say a Drug Enforcement Administration investigation revealed that Novel Laboratories failed to account for large amounts of oxycodone, hydrocodone and temazepam over a two-year period beginning in 2019.
